Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure. [electronic resource]
Producer: 20200116Description: 4665-4674 p. digitalISSN:- 1643-3750
- Adult
- Antiviral Agents -- therapeutic use
- Biomarkers, Pharmacological -- blood
- DNA, Viral -- blood
- Female
- Guanine -- analogs & derivatives
- Hepatitis B Surface Antigens -- analysis
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- blood
- Humans
- Interferon alpha-2 -- pharmacokinetics
- Interferon-alpha -- pharmacology
- Male
- Middle Aged
- Polyethylene Glycols -- pharmacology
- Recombinant Proteins -- pharmacology
- Seroconversion
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.